LYFAX Mutual Fund
LYFAX Mutual Fund
LYFAX Mutual Fund
AlphaCentric Life Sciences and Healthcare Fund Class A
LYFAX Mutual Fund Overview
LYFAX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class A) is managed by Alpha Centric Fund with $5.0M in net assets. LYFAX expense ratio is 1.71%, holding 63 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.
LYFAX performance shows a YTD return of 17.96%. The 1-year return is 54.34% and the 5-year return is 8.48%. LYFAX dividend yield stands at 1.21%, paid annually.
LYFAX top holdings include First American Treasury Obligations Fund (7.7%), Gilead Sciences Inc (7.2%), Astrazeneca Plc (5.6%), Vertex Pharmaceuticals Inc (5.6%), Ionis Pharmaceuticals, Inc. Com USD0.001 (3.7%). Go to all LYFAX holdings, LYFAX sectors, or LYFAX dividends.
LYFAX can be compared against other funds. Use LYFAX overlap to find shared positions, or LYFAX vs another fund for a side-by-side view. LYFAX alternatives are available via the screener, along with tax-loss harvesting opportunities.